Gov. Chris Sununu |
ST. HELIER, Jersey – Gov. Chris Sununu (R-NH) joined Novocure for a ceremonial event commemorating the start of construction of its new flagship facility in the heart of downtown Portsmouth, New Hampshire.
The flagship building will provide space for Novocure’s growing employee base in Portsmouth and house a world-class training and development center where partners from around the world can come to learn about Novocure’s Tumor Treating Fields (TTFields) cancer therapy.
William F. (Bill) Doyle |
Sununu delivered remarks before an audience of Novocure employees and local community and business leaders.
“Employers like Novocure help ensure New
Hampshire remains the best state in which to live, work, and raise a family,”
Sununu said.
Sen. Jeanne Shaheen |
“We thank Governor Sununu for his leadership and
support, on behalf of our workforce and the thousands of patients we are able
to serve around the world,” said Bill Doyle, Novocure’s Executive
Chairman.
“Since establishing our U.S. operations in
Portsmouth more than 15 years ago, the Seacoast has become an important part of
our company’s history.
Sen. Maggie Hassan |
While they were unable to attend due to scheduling conflicts, U.S. Senators Jeanne Shaheen (D-NH) and Maggie Hassan (D-NH), as well as U.S. Rep. Chris Pappas (D-NH-01) provided prepared remarks that were read aloud by representatives from their offices.
“This achievement is a testament to your
thorough work, your focus on building community among employees and your
commitment to sharing your expertise and insights with physicians and partners
from around the world. Much has changed since you planted roots in Portsmouth
more than 15 years ago,” said Shaheen.
Chris Pappas |
“The work being done here at Novocure is an
important part of the growing BioTech/MedTech economy in New Hampshire that is
leading the way in developing cutting-edge products and services that improve
the health and well-being of our people.”
“Founded on the concept of approaching the most
daunting challenges in healthcare by reimagining how science can be used,
Novocure has been a leader in its field,” said Pappas.
“Your work to pioneer new cancer treatments has
the potential to change the lives of patients around the country and around the
world.”
Headquartered in Jersey, and with a growing global footprint, Novocure has regional operating centers in Root, Switzerland, Portsmouth, New Hampshire and Tokyo, as well as a research center in Haifa, Israel.
For
additional information about the company, please visit Novocure.com and follow
@Novocure on LinkedIn and Twitter.
CONTACT:
Alexa
Cangialosi
Account
Executive
Violet
PR
8 Hillside Avenue, LL1
Montclair, NJ 07042
845.825.1271